Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

[HTML][HTML] Follicular thyroid carcinoma

M Sobrinho-Simoes, C Eloy, J Magalhaes, C Lobo… - Modern Pathology, 2011 - Elsevier
Follicular thyroid carcinoma is being diagnosed less and less frequently despite the
increasing incidence of well-differentiated thyroid carcinomas everywhere. This review will …

Encapsulated follicular thyroid tumor with equivocal nuclear changes, so‐called well‐differentiated tumor of uncertain malignant potential: a morphological …

Z Liu, G Zhou, M Nakamura, E Koike, Y Li… - Cancer …, 2011 - Wiley Online Library
There is a continuous debate regarding the classification of thyroid follicular lesions and the
term “well‐differentiated tumor of uncertain malignant potential (WDT‐UMP)” was recently …

Mutation profiles of follicular thyroid tumors by targeted sequencing

H Duan, X Liu, X Ren, H Zhang, H Wu, Z Liang - Diagnostic Pathology, 2019 - Springer
Background One of the major challenges remaining in the classification of thyroid tumor is
the determination of whether a nodule is benign or malignant. We aimed to characterize the …

Classification of thyroid follicular cell tumors: with special reference to borderline lesions

K Kakudo, Y Bai, Z Liu, Y Li, Y Ito, T Ozaki - Endocrine journal, 2012 - jstage.jst.go.jp
We propose a new classification of thyroid follicular cell tumors which is correlated with
patient's prognosis. It is unique as to two new categories: borderline malignancy between …

Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer

K Kakudo, Y Bai, Z Liu, T Ozaki - Pathology international, 2012 - Wiley Online Library
Papillary thyroid carcinoma (PTC) has long been diagnosed based on its unique nuclear
features (PTC‐N); however, significant observer discrepancies have been reported in the …

[PDF][PDF] Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential

A Nechifor-Boila, R Catana, A Loghin, TG Radu… - Rom J Morphol …, 2014 - rjme.ro
Aim: We aimed to evaluate four immunohistochemical markers (HBME-1, Galectin-3,
Cytokeratin-19 and CD56) used alone or in panels in a series of papillary thyroid carcinoma …

Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management

EA Rakha, S Badve, V Eusebi, JS Reis‐Filho… - …, 2016 - Wiley Online Library
Breast lesions comprise a family of heterogeneous entities with variable patterns of
presentation, morphology and clinical behaviour. The majority of breast lesions are …

The B ethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories

S Önder, P Firat, D Ates - Cytopathology, 2014 - Wiley Online Library
Objective In this study, we investigated the efficacy of the B ethesda system (TBS) for
reporting thyroid cytopathology in determining the risk of malignancy for indeterminate …

Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers

F Acibucu, HS Dökmetaş, Y Tutar… - Experimental and …, 2014 - thieme-connect.com
It has been shown that miRNA 221, 222 and 146b are increasingly expressed while p27
Kip1 is suppressed in papillary thyroid cancer (PTC). We investigated the association …